PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,063,000 | -95.0% | 13,930 | -96.6% | 0.07% | -92.0% |
| Q2 2020 | $21,252,000 | -28.6% | 405,040 | -54.4% | 0.89% | -30.0% |
| Q1 2020 | $29,754,000 | -14.8% | 887,370 | +15.1% | 1.27% | +2.1% |
| Q4 2019 | $34,933,000 | +29.9% | 771,140 | +9.2% | 1.25% | +14.7% |
| Q1 2019 | $26,885,000 | -75.0% | 706,379 | -71.7% | 1.09% | -67.7% |
| Q4 2018 | $107,469,000 | +12.4% | 2,498,128 | +28.4% | 3.36% | +5.9% |
| Q3 2018 | $95,623,000 | +4.5% | 1,945,540 | -31.9% | 3.17% | +9.1% |
| Q2 2018 | $91,510,000 | +27.7% | 2,855,213 | +24.1% | 2.91% | +19.2% |
| Q1 2018 | $71,645,000 | -43.9% | 2,300,000 | -17.9% | 2.44% | -41.4% |
| Q4 2017 | $127,820,000 | +32.0% | 2,800,000 | +8.6% | 4.16% | +28.2% |
| Q3 2017 | $96,805,000 | +13.1% | 2,578,040 | +43.7% | 3.24% | +5.1% |
| Q2 2017 | $85,564,000 | +70.6% | 1,793,799 | +63.1% | 3.09% | +34.2% |
| Q1 2017 | $50,160,000 | -1.4% | 1,100,000 | -30.2% | 2.30% | -20.0% |
| Q4 2016 | $50,873,000 | +99.7% | 1,575,000 | +111.6% | 2.88% | +85.2% |
| Q3 2016 | $25,469,000 | +202.0% | 744,280 | +197.7% | 1.55% | +237.4% |
| Q2 2016 | $8,433,000 | +410.8% | 250,000 | +1062.8% | 0.46% | +360.0% |
| Q4 2015 | $1,651,000 | -85.1% | 21,500 | -82.8% | 0.10% | -83.8% |
| Q4 2014 | $11,083,000 | – | 125,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |